ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
Hawkeye Bio
About
Hawkeye Bio is a medical technology company focused on the early detection of cancer, infectious disease and autoimmune disease.
- 11 - 50
Highlights
Details
- Last Funding Type
- Convertable Note
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Hawkeye Bio is developing patented nanoscale biosensors (NBS) for disease detection. The company's lead clinical program in oncology is focused on the deployment of nanobiosensors to non-invasively detect early stage cancer. Identifying cancer reliably, safely, and affordably at the earliest stage is critical for successful treatment and survival. The NBS are also being evaluated to monitor patients post-treatment to identify cases of minimal residual disease and intercept recurrence. The NBS platform is also being clinically evaluated for applications in infectious and autoimmune disease.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2020 | Convertable Note | — | 1 | — | — | Detail |
| Jan 2, 2018 | Seed | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
NJF Capital
|
— | Convertable Note |
